SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-22-002377
Filing Date
2022-01-18
Accepted
2022-01-18 16:00:27
Documents
1
Group Members
VERTEX VENTURE MANAGEMENT PTE. LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea154120-13gvertex2_elevat.htm SC 13G 55008
  Complete submission text file 0001213900-22-002377.txt   56676
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92657 | Film No.: 22535168
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 250 NORTH BRIDGE ROAD #11-01 RAFFLES CITY TOWER SINGAPORE U0 179101
Business Address 250 NORTH BRIDGE ROAD #11-01 RAFFLES CITY TOWER SINGAPORE U0 179101 65-68288050
Vertex Global HC Fund II Pte. Ltd. (Filed by) CIK: 0001868847 (see all company filings)

IRS No.: 000000000
Type: SC 13G